P1 · Therapeutic area intelligence
Oncology patent intelligence
Anticancer agents, immuno-oncology, ADC, and oncology patent filings — grants, expirations, and assignee activity.
- Patents
- 1,930
Quick answer
1,930 US pharmaceutical patents in our index match Oncology title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.
-
US 6391888
Topical anesthetics useful for treating cancer
expired -
US 6380167
Methods for anti-tumor therapy
expired -
US 6380403
Illudin analogs useful as antitumor agents
expired -
US 6376654
Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof
expired -
US 6368596
Compositions and methods for homoconjugates of antibodies which induce growth arrest or apoptosis of tumor cells
expired -
US 6365768
Interleukin-1 and tumor necrosis factors-&agr; modulators, syntheses of said modulators and methods of using modulators
expired -
US 6365797
Mice models of human prostate cancer progression
expired -
US 6362200
Antitumor dibenzofluorene derivatives
expired -
US 6358736
Method for increasing the antigen presenting ability of leukemia cells
expired -
US 6355619
Peptide tumor cell growth inhibitors
expired -
US 6342216
Therapy of cancer by insect cells containing recombinant baculovirus encoding genes
expired -
US 6342392
Nucleotide and deduced amino acid sequences of tumor gene Int6
expired -
US 6331284
P202 is a tumor suppressor
expired -
US 6331555
Treatment of platelet derived growth factor related disorders such as cancers
expired -
US 6323181
Antitumor agents
expired -
US 6319496
Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof
expired -
US 6312694
Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
expired -
US 6313178
Use of hexahydrolupulones as antibacterial and anticancer agents
expired -
US 6306832
Peptide antiestrogen compositions and methods for treating breast cancer
expired -
US 6305380
Method for treatment of cancer and infectious disease
expired -
US 6299873
Method for improvement of radiation therapy of malignant tumors
expired -
US 6300308
Methods and compositions for inducing autoimmunity in the treatment of cancers
expired -
US 6287537
Radioimmunotherapy of lymphoma using anti-CD20 antibodies
expired -
US 6281196
Isolation and structural elucidation of the human cancer cell growth inhibitory compound denominated agelagalastatin
expired -
US 6277368
Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine
expired -
US 6274729
Use of long-wavelength electromagnetic radiation and photoprotective tumor localizing agents for diagnosis
expired -
US 6270778
Melanoma antigens and their use in diagnostic and therapeutic methods
expired -
US 6268350
Polynucleotides for inhibiting metastasis and tumor cell growth
expired -
US 6261535
Diagnostic methods for targeting the vasculature of solid tumors
expired -
US 6262242
Tumor suppressor designated TS10Q23.3
expired -
US 6261831
Ultra-wide band RF-enhanced chemotherapy for cancer treatmeat
expired -
US 6261791
Method for diagnosing cancer using specific PSCA antibodies
expired -
US 6258845
DFMO and sulindac combination in cancer chemoprevention
expired -
US 6255105
Nucleotide and deduced amino acid sequences of tumor gene Int6
expired -
US 6252093
Total synthesis of antitumor acylfulvenes
expired -
US 6251871
P16 expression constructs and their application in cancer therapy
expired -
US 6248351
Human PEA3 is a tumor suppressor for cancer cells
expired -
US 6232086
Method for detecting cancer cells
expired -
US 6224866
Immunotherapy of B cell involvement in progression of solid, nonlymphoid tumors
expired -
US 6211239
Method for treating or preventing breast cancer or leukemia using 6-[3-[1-adamantyl]-4-hydroxyphenyl]-2-naphthalene carboxylic acid (AHPN)
expired -
US 6210917
Method for suppressing multiple drug resistance in cancer cells
expired -
US 6207821
Long-wavelength electromagnetic radiation and photoprotective tumor localizing agents for diagnosis
expired -
US 6207147
Cancer immunotherapy using tumor cells combined with mixed lymphocytes
expired -
US 6207690
Troglitazone compounds for treating climacteric and cancer
expired -
US 6203787
Treating tumors using implants comprising combinations of allogeneic cells
expired -
US 6200765
Non-invasive methods to detect prostate cancer
expired -
US 6201129
Tricyclic derivatives and their use as anti-cancer agents
expired -
US 6200597
Formulation and use of carotenoids in treatment of cancer
expired
Frequently asked questions
How many Oncology patents are indexed?
1,930 patents match our Oncology classifier (title keywords in USPTO records).
Is this legal or medical advice?
No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.